{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:15:55Z","timestamp":1783520155103,"version":"3.55.0"},"reference-count":77,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Leishmaniasis is a parasitic infectious neglected tropical disease transmitted to humans by\nthe parasites of Leishmania species. Mainly, three types of leishmaniases are usually observed: visceral\n(VL), cutaneous (CL), and mucocutaneous leishmaniasis. In many western countries, almost\n700,000 to 1 million people suffer from leishmaniasis, and it is estimated that around 26000 to 65000\ndeaths occur from leishmaniasis. Few drugs are available for its treatment; however, none of them are\nideal for leishmaniasis due to long treatment, discomfort mode of administration, risk of high-level\ntoxicity, high resistance, etc. Hence, so many patients are unable to take complete treatment due to the\nhigh drug resistance. The present review will focus on antileishmanial activity of reported derivatives\nof betacarboline, chalcone, azole, quinoline, quinazoline, benzimidazole, benzadiazapine, thiaazoles,\nsemicarbazone, and hydontoin analogues. We believe that this present study will be helpful for researchers\nto design new antileishmanial agents.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557521666210913115116","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T07:06:11Z","timestamp":1631775971000},"page":"743-757","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Some Scaffolds as Anti-leishmanial Agents: A Review"],"prefix":"10.2174","volume":"22","author":[{"given":"Thatikayala","family":"Mahender","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadhwa","family":"Pankaj","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Singh Pankaj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of\nPharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad 500037, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaidya","family":"Ankur","sequence":"additional","affiliation":[{"name":"Pharmacy College Saifai, Uttar Pradesh University of Medical Sciences, Saifai, Etawah (U.P.), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahu Sanjeev","family":"Kumar","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"Desjeux P.","year":"2004","unstructured":"Desjeux P.; Leishmaniasis: Current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004,27(5),305-318","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","volume":"63","author":"Mitropoulos P.","year":"2010","unstructured":"Mitropoulos P.; Konidas P.; Durkin-Konidas M.; New World cutaneous leishmaniasis: Updated review of current and future diagnosis and treatment. J Am Acad Dermatol 2010,63(2),309-322","journal-title":"J Am Acad Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaad.2014.09.014","volume":"73","author":"Handler M.Z.","year":"2015","unstructured":"Handler M.Z.; Patel P.A.; Kapila R.; Al-Qubati Y.; Schwartz R.A.; Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management. J Am Acad Dermatol 2015,73(6),911-926, 927-928","journal-title":"J Am Acad Dermatol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mpmed.2013.11.010","volume":"42","author":"Moore E.M.","year":"2014","unstructured":"Moore E.M.; Diagnostic approach to tropical skin infections. Medicine (Baltimore) 2014,42(2),73-78","journal-title":"Medicine (Baltimore)"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1590\/S0037-86822005000100005","volume":"38","author":"Lemos J.C.","year":"2005","unstructured":"Lemos J.C.; Lima, Sdo.C. American cutaneous leishmaniasis: Phlebotomine transmission area in the Municipality of Uberl\u00e2ndia, MG. Rev Soc Bras Med Trop 2005,38(1),22-26","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0190-9622(96)80121-6","volume":"34","author":"Grevelink S.A.","year":"1996","unstructured":"Grevelink S.A.; Lerner E.A.; Leishmaniasis. J Am Acad Dermatol 1996,34(2 Pt 1),257-272","journal-title":"J Am Acad Dermatol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40257-015-0114-z","volume":"16","author":"De Vries H.J.","year":"2015","unstructured":"De Vries H.J.; Reedijk S.H.; Schallig H.D.; Cutaneous leishmaniasis: Recent developments in diagnosis and management. Am J Clin Dermatol 2015,16(2),99-109","journal-title":"Am J Clin Dermatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1093\/infdis\/jiz644","volume":"221","author":"Coffeng L.E.","year":"2020","unstructured":"Coffeng L.E.; Le Rutte E.A.; Mu\u00f1oz J.; Adams E.R.; Prada J.M.; de Vlas S.J.; Medley G.F.; Impact of changes in detection effort on control of visceral leishmaniasis in the Indian subcontinent. 2020,221,5546-5553"},{"key":"ref=9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005150","volume":"10","author":"Das A.","year":"2016","unstructured":"Das A.; Karthick M.; Dwivedi S.; Banerjee I.; Mahapatra T.; Srikantiah S.; Chaudhuri I.; Epidemiologic correlates of mortality among symptomatic visceral leishmaniasis cases: Findings from situation assessment in high endemic foci in India. PLoS Negl Trop Dis 2016,10(11)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"S301","DOI":"10.1093\/cid\/ciy007","author":"Le Rutte E.A.","year":"2018","unstructured":"Le Rutte E.A.; Chapman L.A.; Coffeng L.E.; Ruiz-Postigo J.A.; Olliaro P.L.; Adams E.R.; Hasker E.C.; Boelaert M.C.; Hollingsworth T.D.; Medley G.F.; Policy recommendations from transmission modeling for the elimination of visceral leishmaniasis in the Indian subcontinent. Clin Infect Dise 2018(66)(suppl_4),S301-S308","journal-title":"Clin Infect Dise"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.ijantimicag.2010.06.023","volume":"36","author":"Postigo J.A.R.","year":"2010","unstructured":"Postigo J.A.R.; Leishmaniasis in the world health organization eastern mediterranean region. Int J Antimicrob Agents 2010,36(Suppl. 1),S62-S65","journal-title":"Int J Antimicrob Agents"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1051\/parasite\/1990651037","volume":"65","author":"Killick-Kendrick R.","year":"1990","unstructured":"Killick-Kendrick R.; The life-cycle of Leishmania in the sandfly with special reference to the form infective to the vertebrate host. Ann Parasitol Hum Comp 1990,65(Suppl. 1),37-42","journal-title":"Ann Parasitol Hum Comp"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1550-7408.1993.tb04906.x","volume":"40","author":"Pan A.A.","year":"1993","unstructured":"Pan A.A.; Duboise S.M.; Eperon S.; Rivas L.; Hodgkinson V.; Traub-Cseko Y.; McMahon-Pratt D.; Developmental life cycle of Leishmania--cultivation and characterization of cultured extracellular amastigotes. J Eukaryot Microbiol 1993,40(2),213-223","journal-title":"J Eukaryot Microbiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","volume":"21","author":"Croft S.L.","year":"2005","unstructured":"Croft S.L.; Barrett M.P.; Urbina J.A.; Chemotherapy of trypanosomiases and leishmaniasis. Trends Parasitol 2005,21(11),508-512","journal-title":"Trends Parasitol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/jac\/28.3.437","volume":"28","author":"Feddersen A.","year":"1991","unstructured":"Feddersen A.; Sack K.; Experimental studies on the nephrotoxicity of pentamidine in rats. J Antimicrob Chemother 1991,28(3),437-446","journal-title":"J Antimicrob Chemother"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1517\/14656566.4.8.1277","volume":"4","author":"Herbrecht R.","year":"2003","unstructured":"Herbrecht R.; Natarajan-Am\u00e9 S.; Nivoix Y.; Letscher-Bru V.; The lipid formulations of amphotericin B. Expert Opin Pharmacother 2003,4(8),1277-1287","journal-title":"Expert Opin Pharmacother"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1128\/AAC.48.8.3010-3015.2004","volume":"48","author":"Verma N.K.","year":"2004","unstructured":"Verma N.K.; Dey C.S.; Possible mechanism of miltefosine-mediated death of Leishmania donovani. Antimicrob Agents Chemother 2004,48(8),3010-3015","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","volume":"91","author":"Armijos R.X.","year":"2004","unstructured":"Armijos R.X.; Weigel M.M.; Calvopi\u00f1a M.; Mancheno M.; Rodriguez R.; Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Trop 2004,91(2),153-160","journal-title":"Acta Trop"},{"key":"ref=19","first-page":"115","volume":"18","author":"Loiseau P.","year":"2011","unstructured":"Loiseau P.; Cojean S.; Schr\u00e9vel J.; Sitamaquine as a putative antileishmanial drug candidate: From the mechanism of action to the risk of drug resistance. Parasite. J de la Soci\u00e9t\u00e9 Fran\u00e7aise de Parasitologie 2011,18(2),115","journal-title":"J de la Soci\u00e9t\u00e9 Fran\u00e7aise de Parasitologie"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/815023","volume":"2015","author":"de Menezes J.P.B.","year":"2015","unstructured":"de Menezes J.P.B.; Guedes C.E.S.; Petersen A.L.D.O.A.; Fraga D.B.M.; Veras P.S.T.; Advances in development of new treatment for leishmaniasis. BioMed Research International 2015,2015","journal-title":"BioMed Research International"},{"key":"ref=21","first-page":"97","volume":"51","author":"Franco J.","year":"2018","unstructured":"Franco J.; Scarone L.; Comini M.A.; Annual reports in medicinal chemistry; Elsevier 2018,51,97-133","journal-title":"Elsevier"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/B978-0-12-815723-7.00007-9","author":"Mathew N.S.","year":"2019","unstructured":"Mathew N.S.; Negi P.S.;  Discovery and development of therapeutics from natural products against neglected tropical diseases 2019,241-292","journal-title":"Discovery and development of therapeutics from natural products against neglected tropical diseases"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ejmech.2014.07.006","volume":"97","author":"Ashok P.","year":"2015","unstructured":"Ashok P.; Lathiya H.; Murugesan S.; Manzamine alkaloids as antileishmanial agents: A review. Eur J Med Chem 2015,97,928-936","journal-title":"Eur J Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.drudis.2015.04.006","volume":"20","author":"Rajasekaran R.","year":"2015","unstructured":"Rajasekaran R.; Chen Y-P.P.; Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs. Drug Discov Today 2015,20(8),958-968","journal-title":"Drug Discov Today"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40409-018-0163-x","volume":"24","author":"Rodrigues C.A.","year":"2018","unstructured":"Rodrigues C.A.; dos Santos P.F.; da Costa M.O.L.; Pavani T.F.A.; Xander P.; Geraldo M.M.; Mengarda A.; de Moraes J.; Rando D.G.G.; 4-Phenyl-1, 3-thiazole-2-amines as scaffolds for new antileishmanial agents. J Venom Anim Toxins Incl Trop Dis 2018,24(1),1-10","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1016\/j.bmc.2017.03.051","volume":"25","author":"Stroppa P.H.F.","year":"2017","unstructured":"Stroppa P.H.F.; Antinarelli L.M.R.; Carmo A.M.L.; Gameiro J.; Coimbra E.S.; da Silva A.D.; Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis. Bioorg Med Chem 2017,25(12),3034-3045","journal-title":"Bioorg Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.actatropica.2016.12.027","volume":"167","author":"Shokri A.","year":"2017","unstructured":"Shokri A.; Emami S.; Fakhar M.; Teshnizi S.H.; Keighobadi M.; In vitro antileishmanial activity of novel azoles (3-imidazolylflavanones) against promastigote and amastigote stages of Leishmania major. Acta Trop 2017,167,73-78","journal-title":"Acta Trop"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.ejmech.2016.12.019","volume":"126","author":"Taha M.","year":"2017","unstructured":"Taha M.; Ismail N.H.; Imran S.; Anouar E.H.; Selvaraj M.; Jamil W.; Ali M.; Kashif S.M.; Rahim F.; Khan K.M.; Adenan M.I.; Synthesis and molecular modelling studies of phenyl linked oxadiazole-phenylhydrazone hybrids as potent antileishmanial agents. Eur J Med Chem 2017,126,1021-1033","journal-title":"Eur J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejmech.2015.02.038","volume":"94","author":"Bekhit A.A.","year":"2015","unstructured":"Bekhit A.A.; Hassan A.M.; Abd El Razik H.A.; El-Miligy M.M.; El-Agroudy E.J.; Bekhit, Ael-D. New heterocyclic hybrids of pyrazole and its bioisosteres: Design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents. Eur J Med Chem 2015,94,30-44","journal-title":"Eur J Med Chem"},{"key":"ref=30","author":"Draper J.","year":"2014","unstructured":"Draper J.; Synthesis of pyridyl ethyl amides as potential antitrypanosomal agents, and synthesis of arylimidamide-azole hybrids as potential antileishmanial agents. MS thesis USA; Georgia State University 2014"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.parint.2018.12.006","volume":"69","author":"Keighobadi M.","year":"2019","unstructured":"Keighobadi M.; Emami S.; Fakhar M.; Shokri A.; Mirzaei H.; Hosseini Teshnizi S.; Repurposing azole antifungals into antileishmanials: Novel 3-triazolylflavanones with promising in vitro antileishmanial activity against Leishmania major. Parasitol Int 2019,69,103-109","journal-title":"Parasitol Int"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.actatropica.2010.10.011","volume":"117","author":"Verma A.","year":"2011","unstructured":"Verma A.; Srivastava S.; Sane S.A.; Marrapu V.K.; Srinivas N.; Yadav M.; Bhandari K.; Gupta S.; Antileishmanial activity of benzocycloalkyl azole oximino ethers: The conformationally constraint analogues of oxiconazole. Acta Trop 2011,117(2),157-160","journal-title":"Acta Trop"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"7451","DOI":"10.1016\/j.bmcl.2011.09.134","volume":"21","author":"dos Santos M.S.","year":"2011","unstructured":"dos Santos M.S.; Oliveira M.L.; Bernardino A.M.; de L\u00e9o R.M.; Amaral V.F.; de Carvalho F.T.; Leon L.L.; Canto-Cavalheiro M.M.; Synthesis and antileishmanial evaluation of 1-aryl-4-(4,5-dihydro-1H-imidazol-2-yl)-1H-pyrazole derivatives. Bioorg Med Chem Lett 2011,21(24),7451-7454","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.ejmech.2011.02.021","volume":"46","author":"Marrapu V.K.","year":"2011","unstructured":"Marrapu V.K.; Mittal M.; Shivahare R.; Gupta S.; Bhandari K.; Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents. Eur J Med Chem 2011,46(5),1694-1700","journal-title":"Eur J Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.bmcl.2011.01.026","volume":"21","author":"Marrapu V.K.","year":"2011","unstructured":"Marrapu V.K.; Srinivas N.; Mittal M.; Shakya N.; Gupta S.; Bhandari K.; Design and synthesis of novel tetrahydronaphthyl azoles and related cyclohexyl azoles as antileishmanial agents. Bioorg Med Chem Lett 2011,21(5),1407-1410","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"8214","DOI":"10.1021\/jm201215n","volume":"54","author":"Papadopoulou M.V.","year":"2011","unstructured":"Papadopoulou M.V.; Trunz B.B.; Bloomer W.D.; McKenzie C.; Wilkinson S.R.; Prasittichai C.; Brun R.; Kaiser M.; Torreele E.; Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents. J Med Chem 2011,54(23),8214-8223","journal-title":"J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.bmcl.2006.11.004","volume":"17","author":"Clark R.L.","year":"2007","unstructured":"Clark R.L.; Carter K.C.; Mullen A.B.; Coxon G.D.; Owusu-Dapaah G.; McFarlane E.; Duong Thi M.D.; Grant M.H.; Tettey J.N.; Mackay S.P.; Identification of the benzodiazepines as a new class of antileishmanial agent. Bioorg Med Chem Lett 2007,17(3),624-627","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.bmcl.2008.05.013","volume":"19","author":"Palma A.","year":"2009","unstructured":"Palma A.; Y\u00e9pes A.F.; Leal S.M.; Coronado C.A.; Escobar P.; Synthesis and in vitro activity of new tetrahydronaphtho[1,2-b]azepine derivatives against Trypanosoma cruzi and Leishmania chagasi parasites. Bioorg Med Chem Lett 2009,19(8),2360-2363","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.126725","volume":"30","author":"Abdelhameed A.","year":"2020","unstructured":"Abdelhameed A.; Liao X.; McElroy C.A.; Joice A.C.; Rakotondraibe L.; Li J.; Slebodnick C.; Guo P.; Wilson W.D.; Werbovetz K.A.; Synthesis and antileishmanial evaluation of thiazole orange analogs. Bioorg Med Chem Lett 2020,30(1)","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1021\/acsinfecdis.8b00355","volume":"5","author":"Revuelto A.","year":"2019","unstructured":"Revuelto A.; Ruiz-Santaquiteria M.; de Lucio H.; Gamo A.; Carriles A.A.; Guti\u00e9rrez K.J.; S\u00e1nchez-Murcia P.A.; Hermoso J.A.; Gago F.; Camarasa M-J.; Jim\u00e9nez-Ruiz A.; Vel\u00e1zquez S.; Pyrrolopyrimidine vs imidazole-phenyl-thiazole scaffolds in nonpeptidic dimerization inhibitors of leishmania infantum trypanothione reductase. ACS Infect Dis 2019,5(6),873-891","journal-title":"ACS Infect Dis"},{"key":"ref=41","first-page":"1816","volume":"18","author":"Sadat-Ebrahimi S.E.","year":"2019","unstructured":"Sadat-Ebrahimi S.E.; Mirmohammadi M.; Mojallal Tabatabaei Z.; Azimzadeh Arani M.; Jafari-Ashtiani S.; Hashemian M.; Foroumadi P.; Yahya-Meymandi A.; Moghimi S.; Moshafi M.H.; Norouzi P.; Kabudanian Ardestani S.; Foroumadi A.; Novel 5-(nitrothiophene-2-yl)-1,3,4-thiadiazole derivatives: Synthesis and antileishmanial activity against promastigote stage of leishmania major. Iran J Pharm Res 2019,18(4),1816-1822","journal-title":"Iran J Pharm Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1016\/j.bmcl.2017.05.071","volume":"27","author":"Col\u00edn-Lozano B.","year":"2017","unstructured":"Col\u00edn-Lozano B.; Le\u00f3n-Rivera I.; Chan-Bacab M.J.; Ortega-Morales B.O.; Moo-Puc R.; L\u00f3pez-Guerrero V.; Hern\u00e1ndez-N\u00fa\u00f1ez E.; Arg\u00fcello-Garcia R.; Scior T.; Barbosa-Cabrera E.; Navarrete-V\u00e1zquez G.; Synthesis, in vitro and in vivo giardicidal activity of nitrothiazole-NSAID chimeras displaying broad antiprotozoal spectrum. Bioorg Med Chem Lett 2017,27(15),3490-3494","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejps.2017.05.005","volume":"105","author":"Alian\u00e7a A.S.D.S.","year":"2017","unstructured":"Alian\u00e7a A.S.D.S.; Oliveira A.R.; Feitosa A.P.S.; Ribeiro K.R.C.; de Castro M.C.A.B.; Leite A.C.L.; Alves L.C.; Brayner F.A.; in vitro evaluation of cytotoxicity and leishmanicidal activity of phthalimido-thiazole derivatives. Eur J Pharm Sci 2017,105,1-10","journal-title":"Eur J Pharm Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejmech.2016.04.010","volume":"117","author":"Papadopoulou M.V.","year":"2016","unstructured":"Papadopoulou M.V.; Bloomer W.D.; Rosenzweig H.S.; Wilkinson S.R.; Szular J.; Kaiser M.; Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds. Eur J Med Chem 2016,117,179-186","journal-title":"Eur J Med Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"89919","DOI":"10.1039\/C5RA14900B","volume":"5","author":"Ibrar A.","year":"2015","unstructured":"Ibrar A.; Zaib S.; Khan I.; Jabeen F.; Iqbal J.; Saeed A.; Facile and expedient access to bis-coumarin\u2013iminothiazole hybrids by molecular hybridization approach: Synthesis, molecular modelling and assessment of alkaline phosphatase inhibition, anticancer and antileishmanial potential. RSC Advances 2015,5(109),89919-89931","journal-title":"RSC Advances"},{"key":"ref=46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112514","volume":"203","author":"Gon\u00e7alves G.A.","year":"2020","unstructured":"Gon\u00e7alves G.A.; Spillere A.R.; das Neves, G.M.; Kagami, L.P.; von Poser, G.L.; Canto, R.F.S.; Eifler-Lima, V. Natural and synthetic coumarins as antileishmanial agents: A review. Eur J Med Chem 2020,203","journal-title":"Eur J Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.ejmech.2008.03.039","volume":"44","author":"Poorrajab F.","year":"2009","unstructured":"Poorrajab F.; Ardestani S.K.; Emami S.; Behrouzi-Fardmoghadam M.; Shafiee A.; Foroumadi A.; Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: Synthesis and in vitro biological evaluation. Eur J Med Chem 2009,44(4),1758-1762","journal-title":"Eur J Med Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ejmech.2018.03.014","volume":"150","author":"Bar\u00e9a P.","year":"2018","unstructured":"Bar\u00e9a P.; Barbosa V.A.; Bid\u00f3ia D.L.; de Paula J.C.; Stefanello T.F.; da Costa W.F.; Nakamura C.V.; Sarragiotto M.H.; Synthesis, antileishmanial activity and mechanism of action studies of novel \u03b2-carboline-1,3,5-triazine hybrids. Eur J Med Chem 2018,150,579-590","journal-title":"Eur J Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1039\/C4MD00298A","volume":"6","author":"Chauhan S.S.","year":"2015","unstructured":"Chauhan S.S.; Pandey S.; Shivahare R.; Ramalingam K.; Krishna S.; Vishwakarma P.; Siddiqi M.; Gupta S.; Goyal N.; Chauhan P.M.; Novel \u03b2-carboline\u2013quinazolinone hybrid as an inhibitor of Leishmania donovani trypanothione reductase: Synthesis, molecular docking and bioevaluation. MedChemComm 2015,6(2),351-356","journal-title":"MedChemComm"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1016\/j.bmcl.2014.06.030","volume":"24","author":"Manda S.","year":"2014","unstructured":"Manda S.; Khan S.I.; Jain S.K.; Mohammed S.; Tekwani B.L.; Khan I.A.; Vishwakarma R.A.; Bharate S.B.; Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-\u03b2-carbolines. Bioorg Med Chem Lett 2014,24(15),3247-3250","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.biopha.2011.12.006","volume":"66","author":"Gellis A.","year":"2012","unstructured":"Gellis A.; Dum\u00e8tre A.; Lanzada G.; Hutter S.; Ollivier E.; Vanelle P.; Azas N.; Preparation and antiprotozoal evaluation of promising \u03b2-carboline alkaloids. Biomed Pharmacother 2012,66(5),339-347","journal-title":"Biomed Pharmacother"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1016\/j.ejmech.2010.04.004","volume":"45","author":"Kumar R.","year":"2010","unstructured":"Kumar R.; Khan S.; Verma A.; Srivastava S.; Viswakarma P.; Gupta S.; Meena S.; Singh N.; Sarkar J.; Chauhan P.M.; Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-\u03b2-carbolines as antileishmanial agents. Eur J Med Chem 2010,45(8),3274-3280","journal-title":"Eur J Med Chem"},{"key":"ref=53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2020.183473","volume":"1863","author":"Alonso L.","year":"2021","unstructured":"Alonso L.; de Paula J.C.; Bar\u00e9a P.; Sarragiotto M.H.; Ueda-Nakamura T.; Alonso A.; de Souza Fernandes N.; Lancheros C.A.C.; Volpato H.; Lazarin-Bid\u00f3ia D.; Nakamura C.V.; Membrane dynamics in Leishmania amazonensis and antileishmanial activities of \u03b2-carboline derivatives. Biochim Biophys Acta Biomembr 2021,1863(1)","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1016\/j.bmcl.2010.08.119","volume":"20","author":"Chauhan S.S.","year":"2010","unstructured":"Chauhan S.S.; Gupta L.; Mittal M.; Vishwakarma P.; Gupta S.; Chauhan P.M.; Synthesis and biological evaluation of indolyl glyoxylamides as a new class of antileishmanial agents. Bioorg Med Chem Lett 2010,20(21),6191-6194","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejmech.2005.09.007","volume":"41","author":"Kumar A.","year":"2006","unstructured":"Kumar A.; Katiyar S.B.; Gupta S.; Chauhan P.M.; Syntheses of new substituted triazino tetrahydroisoquinolines and \u03b2-carbolines as novel antileishmanial agents. Eur J Med Chem 2006,41(1),106-113","journal-title":"Eur J Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/14756366.2017.1410480","volume":"33","author":"Tonelli M.","year":"2018","unstructured":"Tonelli M.; Gabriele E.; Piazza F.; Basilico N.; Parapini S.; Tasso B.; Loddo R.; Sparatore F.; Sparatore A.; Benzimidazole derivatives endowed with potent antileishmanial activity. J Enzyme Inhib Med Chem 2018,33(1),210-226","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=57","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2859637","volume":"2019","author":"Abdelwahid M.A.","year":"2019","unstructured":"Abdelwahid M.A.; Elsaman T.; Mohamed M.S.; Latif S.A.; Mukhtar M.M.; Mohamed M.A.; Synthesis, characterization, and antileishmanial activity of certain quinoline-4-carboxylic acids. J Chem 2019,2019","journal-title":"J Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cbi.2018.08.003","volume":"293","author":"Calixto S.L.","year":"2018","unstructured":"Calixto S.L.; Glanzmann N.; Xavier Silveira M.M.; da Trindade Granato J.; Gorza Scopel K.K.; Torres de Aguiar T.; DaMatta R.A.; Macedo G.C.; da Silva A.D.; Coimbra E.S.; Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp. Chem Biol Interact 2018,293,141-151","journal-title":"Chem Biol Interact"},{"key":"ref=59","first-page":"1516","volume":"20","author":"Malghani Z.","year":"2020","unstructured":"Malghani Z.; Khan A.-U.; Faheem M.; Danish M.Z.; Nadeem H.; Ansari S.F.; Maqbool M.; Molecular docking, antioxidant, anticancer and antileishmanial effects of newly synthesized quinoline derivatives. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 2020,20(13),1516-1529","journal-title":"Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejmech.2018.05.014","volume":"154","author":"Upadhyay A.","year":"2018","unstructured":"Upadhyay A.; Kushwaha P.; Gupta S.; Dodda R.P.; Ramalingam K.; Kant R.; Goyal N.; Sashidhara K.V.; Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents. Eur J Med Chem 2018,154,172-181","journal-title":"Eur J Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.exppara.2016.10.009","volume":"171","author":"Antinarelli L.M.R.","year":"2016","unstructured":"Antinarelli L.M.R.; Souza I.O.; Glanzmann N.; Almeida A.D.; Porcino G.N.; Vasconcelos E.G.; da Silva A.D.; Coimbra E.S.; Aminoquinoline compounds: Effect of 7-chloro-4-quinolinylhydrazone derivatives against Leishmania amazonensis. Exp Parasitol 2016,171,10-16","journal-title":"Exp Parasitol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ejmech.2016.08.049","volume":"124","author":"Yousuf M.","year":"2016","unstructured":"Yousuf M.; Mukherjee D.; Dey S.; Pal C.; Adhikari S.; Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani. Eur J Med Chem 2016,124,468-479","journal-title":"Eur J Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cbi.2016.10.017","volume":"260","author":"Coimbra E.S.","year":"2016","unstructured":"Coimbra E.S.; Antinarelli L.M.; Silva N.P.; Souza I.O.; Meinel R.S.; Rocha M.N.; Soares R.P.; da Silva A.D.; Quinoline derivatives: Synthesis, leishmanicidal activity and involvement of mitochondrial oxidative stress as mechanism of action. Chem Biol Interact 2016,260,50-57","journal-title":"Chem Biol Interact"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejmech.2012.04.029","volume":"54","author":"Paloque L.","year":"2012","unstructured":"Paloque L.; Verhaeghe P.; Casanova M.; Castera-Ducros C.; Dum\u00e8tre A.; Mbatchi L.; Hutter S.; Kraiem-M\u2019rabet M.; Laget M.; Remusat V.; Rault S.; Rathelot P.; Azas N.; Vanelle P.; Discovery of a new antileishmanial hit in 8-nitroquinoline series. Eur J Med Chem 2012,54,75-86","journal-title":"Eur J Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1128\/AAC.01299-10","volume":"55","author":"Loiseau P.M.","year":"2011","unstructured":"Loiseau P.M.; Gupta S.; Verma A.; Srivastava S.; Puri S.K.; Sliman F.; Normand-Bayle M.; Desmaele D.; In vitro activities of new 2-substituted quinolines against Leishmania donovani. Antimicrob Agents Chemother 2011,55(4),1777-1780","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s11030-016-9693-8","volume":"20","author":"Enciso E.","year":"2016","unstructured":"Enciso E.; Sarmiento-S\u00e1nchez J.I.; L\u00f3pez-Moreno H.S.; Ochoa-Ter\u00e1n A.; Osuna-Mart\u00ednez U.; Beltr\u00e1n-L\u00f3pez E.; Synthesis of new quinazolin-2,4-diones as anti-Leishmania mexicana agents. Mol Divers 2016,20(4),821-828","journal-title":"Mol Divers"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/j.bmcl.2009.03.020","volume":"19","author":"Kumar S.","year":"2009","unstructured":"Kumar S.; Shakya N.; Gupta S.; Sarkar J.; Sahu D.P.; Synthesis and biological evaluation of novel 4-(hetero) aryl-2-piperazino quinazolines as anti-leishmanial and anti-proliferative agents. Bioorg Med Chem Lett 2009,19(9),2542-2545","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.exppara.2019.04.003","volume":"201","author":"Cavalcanti de Queiroz A.","year":"2019","unstructured":"Cavalcanti de Queiroz A.; Alves M.A.; Barreiro E.J.; Lima L.M.; Alexandre-Moreira M.S.; Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis. Exp Parasitol 2019,201,57-66","journal-title":"Exp Parasitol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1016\/j.bmcl.2015.05.072","volume":"25","author":"Passalacqua T.G.","year":"2015","unstructured":"Passalacqua T.G.; Dutra L.A.; de Almeida L.; Vel\u00e1squez A.M.A.; Torres F.A.E.; Yamasaki P.R.; dos Santos M.B.; Regasini L.O.; Michels P.A.; Bolzani; Graminha, M.A. Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds. Bioorg Med Chem Lett 2015,25(16),3342-3345","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejmech.2018.04.033","volume":"152","author":"Tejer\u00eda A.","year":"2018","unstructured":"Tejer\u00eda A.; P\u00e9rez-Pertejo Y.; Reguera R.M.; Bala\u00f1a-Fouce R.; Alonso C.; Gonz\u00e1lez M.; Rubiales G.; Palacios F.; Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation. Eur J Med Chem 2018,152,137-147","journal-title":"Eur J Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exppara.2013.11.003","volume":"136","author":"de Mello T.F.","year":"2014","unstructured":"de Mello T.F.; Bitencourt H.R.; Pedroso R.B.; Aristides S.M.; Lonardoni M.V.; Silveira T.G.; Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis. Exp Parasitol 2014,136,27-34","journal-title":"Exp Parasitol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejmech.2018.04.057","volume":"152","author":"Ortalli M.","year":"2018","unstructured":"Ortalli M.; Ilari A.; Colotti G.; De Ionna I.; Battista T.; Bisi A.; Gobbi S.; Rampa A.; Di Martino R.M.C.; Gentilomi G.A.; Varani S.; Belluti F.; Identification of chalcone-based antileishmanial agents targeting trypanothione reductase. Eur J Med Chem 2018,152,527-541","journal-title":"Eur J Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.ejmech.2018.03.047","volume":"150","author":"de Mello M.V.P.","year":"2018","unstructured":"de Mello M.V.P.; Abrahim-Vieira B.A.; Domingos T.F.S.; de Jesus J.B.; de Sousa A.C.C.; Rodrigues C.R.; Souza A.M.T.; A comprehensive review of chalcone derivatives as antileishmanial agents. Eur J Med Chem 2018,150,920-929","journal-title":"Eur J Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1016\/j.bmc.2011.05.055","volume":"19","author":"Barbosa T.","year":"2011","unstructured":"Barbosa T.; Sousa S.; Amorim F.; Rodrigues Y.; de Assis P.; C.; Caldas, J.P.A.; Oliveira, M.R.; Vasconcellos, M.L.A.A. Bioorg Med Chem 2011,19,4250","journal-title":"Bioorg Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1128\/AAC.02529-15","volume":"60","author":"Baquedano Y.","year":"2016","unstructured":"Baquedano Y.; Alcolea V.; Toro M.\u00c1.; Guti\u00e9rrez K.J.; Nguewa P.; Font M.; Moreno E.; Espuelas S.; Jim\u00e9nez-Ruiz A.; Palop J.A.; Plano D.; Sanmart\u00edn C.; Novel heteroaryl selenocyanates and diselenides as potent antileishmanial agents. Antimicrob Agents Chemother 2016,60(6),3802-3812","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bmcl.2009.11.033","volume":"20","author":"Aponte J.C.","year":"2010","unstructured":"Aponte J.C.; Castillo D.; Estevez Y.; Gonzalez G.; Arevalo J.; Hammond G.B.; Sauvain M.; In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic chalcones. Bioorg Med Chem Lett 2010,20(1),100-103","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00706-008-0063-9","volume":"140","author":"Elgazwy A-S.S.H.","year":"2009","unstructured":"Elgazwy A-S.S.H.; Atta-Allha S.R.; Keshk S.M.; Synthesis of 5-spirocyclohexyl-2, 4-dithiohydantoin derivatives: A potential anti-leishmaniasis agent. Monatshefte f\u00fcr Chemie-Chemical Monthly 2009,140(2),243","journal-title":"Monatshefte f\u00fcr Chemie-Chemical Monthly"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557521666210913115116","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/196430\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557521666210913115116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T05:24:30Z","timestamp":1656566670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/196430\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557521666210913115116","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}